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1. Introduction 
The definitive identification of two new lignans, 
with the structures 2,3-his-(3’-hydroxybenzyl)- 
butyrolactone and 2,3-bis-(3’-hydroxybenzyl)-butane- 
1,4diol isolated from the urine of humans and sev- 
eral animal species, has been reported [ 1,2]. The 
quantitative urinary excretion of the dibenzybutyro- 
lactone has been shown to peak during the luteal 
phase of the menstrual cycle of women [ 1,3] and the 
vervet monkey [4] and in pregnancy maximum 
excretion of this compound occurred between weeks 
14-22 of gestation [3]. The urinary excretion of 
these compounds by men is quantitatively similar to 
that in the follicular phase of normal ovulating 
women [3]. 
These compounds are almost exclusively excreted 
in urine as acidic conjugates [ 1,4] and we show using 
a combined liquid chromatography and gas chroma- 
tography-mass spectrometric (GC-MS) method, 
developed for the analysis of steroid conjugates [S], 
that these conjugates are principally glucuronides. 
2. Experimental 
2.1 . Urine samples 
Daily urine collections were obtained frQm healthy 
male and female human subjects (aged 6-62 years) 
and stored at -20°C immediately after collection to 
minimise possible bacterial degradation and artefact 
formation. 
2.2. Extraction and conjugate separation 
Complete details and the evaluation of the tech- 
niques appear in [5]. Lignans were extracted from 
ElsevierfNorth-Holland Biomedical Press 
urine samples on a column of Amberlite XAD-2 
(Rohm and Haas, Philadelphia, PA). The extract was 
then passed through a column of cation exchange gel, 
SP-Sephadex C-25 (Pharmacia Fine Chemicals, 
Uppsala) prior to separating the lignans according to 
their mode of conjugation on a small column of the 
lipophilic strong anion exchange gel triethylamino- 
hydroxypropyl Sephadex LH-20, TEAP-LH-20 [5]. 
Neutral compounds were eluted from the column 
with aqueous methanol. The stepwise elution of 
unconjugated phenolic compounds, glucuronide con- 
jugates, monosulphate and disulphate conjugates, was 
achieved with the solvents 72% aqueous methanol 
saturated with carbon dioxide, 0.4 M formic acid, 
0.3 M acetic acid-potassium acetate (pH 6.5) and 
0.5 M potassium acetate (pH lo), respectively [5 1. 
2.3. Unconjugated lignans 
Those isolated in the free phenolic fraction were 
converted to trimethylsilyl (TMS) ether derivatives 
and analysed by GC. 
2.4. Lignan glucuronides 
These were analysed as intact derivatives and after 
removal of the glucuronic acid moiety. The former 
analysis was performed after methylating the car- 
boxy1 group of the glucuronide with diazomethane 
(under these conditions the free phenolic hydroxyl 
group of the lignan glucuronide does not react [2]) 
and purifying the methyl ester derivatives, dissolved 
in methanol, on a column of TEAP-LH-20 gel. After 
washing the column with methanol the conjugated 
lignan derivatives (which possess a phenolic group) 
were eluted by methanol saturated with carbon diox- 
ide. The hydroxyl groups of the lignan glucuronide 
methyl esters were then convered to TMS ether deriv- 
atives and analysed by GC-MS. 
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2 S. ~e~onj~gation of the gZ~curu~ide conjugates 
Enzymatic hydrolysis was achieved using two dif- 
ferent @lucuronidase preparations. The dried sample 
was dissolved in 5 ml 0.2 M sodium acetate buffer 
(pH 4.5). Enzyme was then added, 1 mg &glucu- 
ronidase purified from bovine liver equivalent to 
IO 000 Fishman Units (Sigma St Louis, MO) or 
0.3 ml Heiix pomatia digestive juice equivalent to 
30 000 Fishman Units (L’lndustrie Biologique 
Francaise, Gennevilliers) and the sample incubated 
at either 37°C for 24 h or at 62’C for 1 h, respec- 
tively. The liberated lignans were then extracted on 
Amberlite XAD-2 and purified on TEAP-LH-20 as 
in [4,5]. 
Removal of the glucuronic acid moiety was also 
performed by oxidative cleavage with periodate [6] 
which produces formate esters of the glucuronides. 
After reaction the mixture was diluted with water 
and the products extracted by ethyl acetate. The sol- 
vent was evaporated, the products redissolved in 
methanol and purified on a column of TEAP-LH-20 
gel. During this purification procedure, hydrolysis of 
the formate esters occurs on this basic ion exchanger 
[7]. The free lignans obtained were converted to TMS 
ether derivatives and analysed by GC-MS. 
2.6. Lignan sulphates 
The mono- and disulphate fractions were solvo- 
lysed in acidified tetr~lydrofuran (4 mM sulphuric 
acid) [5,8]. The liberated lignans were then purified 
on small columns of TEAP-LH-20 [S] and TMS ether 
derivatives prepared. 
2.7. Preparation of TMS ether and deuterium labelled 
TMS ether de~~ati~es 
TMS ethers were prepared by addition of 100 ~1 
pyridine:hexamethyldisilazane:trimethylchlorosi.lane 
(3:2: 1, by vol.) and heating at 60°C for 1 h. The 
silylation reagehts were removed under a stream of 
nitrogen and the derivatives redissolved in hexane. 
Deuterium (do)-labe~ed TMS ethers were prepared 
by addition of 100 ~1 trimethyl-2Hgchlorosilane: 
pyridine (20: 1, v/v) using the above conditions. 
2.8. Gas chromatography 
GC was done on a Pye 104 gas chromatograph 
equipped with a flame ionisation detector and hous- 
ing a 20 m X 0.3 mm open-tubular glass capillary col- 
umn coated with SE-30 [9]. Samples were introduced 
via an all-glass, solid injection system [lo]. Nitrogen 
50 
was the carrier gas with an inlet pressure of 50 kPa, 
giving a flow rate through the column of -1 ml/min. 
The oven temperature was 255°C. 
2.9. Gas chromatography-mass spectrometv 
GC--MS analysis was done on a modified LKB 9000 
instrument [ 1 I] housing an open-tubular glass capil- 
lary column (25 m X 0.3 mm) coated with SE-30, 
heated at 250°C and connected to the ion source via 
a single stage adjustable jet separator [ 121. 
The derivatised lignan glucuronides were chroma- 
tographed on a conventional 1.5% SE-30 packed col- 
umn (1 m X 3.4 mm) at 255°C. Temperatures of the 
molecular separator and the ion source were 275°C 
and 290°C, respectively; energy of bombarding elec- 
trons, 22.5 eV; ionising current, 60 MA and accelerat- 
ing voltage, 3.5 kV. Repetitive magnetic scanning 
(usually 8-10 sc~s/min) over the mass~charge (m/z) 
range O-800 amu, was initiated after a suitable delay 
from the time of sample injection. Methods for the 
computerised evaluation of the mass spectral data 
have been described [ 131. Quantification with higher 
sensitivity was obtained by operating the instrument 
in a singfe ion monitoring mode, recording the ion of 
m/z 180. 
2 .lO. Identification and quantification of lignans 
Identification was based upon the GC retention 
time, the complete mass spectrum and partial mass 
spectra obtained from fragment ion current (FIC) 
chromatograms constructed of characteristic ions 
given by the lignan derivatives. An estimation of the 
amount of lignans present in the hydrolysed glucu- 
ronide fractions was obtained by comparison of the 
peak area response with the peak area obtained from 
a known amount of internal standard, So-cholestan- 
3a-al added prior to derivatisation. 
3. Results and discussion 
3 .l . identification of lignan conjugates 
Circumstantial evidence for the existence of glucu- 
ronide conjugates of the lignans, 2,3-bis-(3’-hydroxy- 
benzyl)-butyrolactone and 2,3-bis(3’-hydroxy- 
benzyl)-butane-l pdiol, was obtained from their 
chromatographic mobilities on the lipophilic strong 
anion exchanger, TEAP-LH-20, and from the finding 
that these lignans were hydrolysed by &glucuronidase 
preparations [4]. Oxidation with periodate and mild 
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alkali treatment also resulted in formation of the free 
lignans, reactions that would be expected for glucu- 
ronide conjugates (71. Furthermore, when the Me 
ester-TMS ether derivatives of the intact lignan 
glucuronides were analysed by GC-MS, their reten- 
tion times on a SE-30 column were l3-14.times 
longer than the corresponding TMS ether derivatives 
of the free compounds. Similar differences in reten- 
tion times have been reported for Me ester-TMS 
ether derivatives of bile acid glucuronides [14,15]. 
Definitive evidence for the occurrence of these lig- 
nans in urine as glucuronide conjugates was obtained 
by GC-MS. The mass spectra of the Me ester-TMS 
ether derivative (upper panel) and the Me ester- 
deuterated TMS ether (lower panel) derivative of the 
glucuronide conjugates of 2,3-his-(3’-hydroxybenzyl) 
butyrolactone are compared in fig.1. In common with 
the mass spectra of derivatives of glucuronide con- 
jugates of oestrogens [ 161 the intensity of the molec- 
ular ion (M’) m/z 776 in the Me ester-TMS ether of 
this lignan glucuronide is negligible. The ions m/z 761 
(M-15),m/z 671 (M-[15 +90])andm/z 581 
(M-[15 + 2 X 901) arise out of the loss of a methyl 
group from the molecular ion and the subsequent loss 
of one and two derivatised hydroxyl groups, respec- 
tively, but all of these fragments are of relatively low 
intensity. The origin of ion m/z 484 (M-292) is 
unknown, but it could possibly represent the aglycon 
and a 2carbon unit of the glucuronide skeleton with 
a trimethylsilanol group. The loss of 334 mass units, 
giving rise to the ion m/z 442, however, is charac- 
teristic of aromatic glucuronides 1161, and is formed 
by cleavage of the glucuronic acid from the molecule 
and the transfer of a silyl group from the glucuronic 
acid moiety [ 161 to the lignan. The ion m/z I80 
already described is a fragment derived from cleavage 
of the aromatic ring of the lignan and is the base peak 
in the mass spectrum of the TMS ether of the uncon- 
jugated lignan [ 1,2,4]. The fragmentation of the 
glucuronic acid moiety described in [ 16,171 leads to 
the occurrence of the typical ions m/z 406, m/z 407, 
m/z 317 (base peak) and m/z 275 which contain the 
carboxyl group and the ions m/z 2 17 and m/z 204. 
The ion m/z 406 is characteristic of aromatic glucu- 
ronides representing the loss of a proton from the 
glucuronic acid moiety. The ion m/z 3 17 is fre- 
quently the base peak in the spectra of steroid glucu- 
ronide conjugates and the occurrence of these series 
of ions provides definitive identification of a glucu- 
ronide conjugate. 
The smaller amounts of the lignan 2,3-bis- 
(3’-hydroxybenzyi)-butane-I ,4diol present in human 
urine has made the definitive identification of the 
glucuronide conjugate from the complete mass spec- 
trum difficult. When computer FTC chromatograms 
are constructed however, for the above ions, which 
are characteristic of the Me ester-TMS derivative of 
glucuronides and the TMS ether derivative of the lig- 
nan [4] (figd) it can be seen from the relative inten- 
sities and from the coincidence in peaking of the ions, 
that the butanediol (II) is also excreted in urine con- 
jugated to glucuronic acid. 
The position of conjugation of the glucuronic acid 
group remains to be firmly established. On the basis 
of GC-MS data it was only possible to establish the 
presence of an aromatic glucuronide, and with two 
Fig.1 _ Mass spectra of Me ester-TMS ethers (upper panel) and Me ester-d*-TMS ethers (lower panel) of 2,3~is-(3’-hydroxybenzyl)- 
butyrolactone-giucuro~de isolated from urine. The origin of ions is given in the text. 
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aromatic rings in the lignan structure, in the case of 
the butyrolactolle the exact position of the glucu- 
ronide group could not be ascertained. 
Confirmation of the presence of lignan mono- and 
d~sulphates was based upon their mobilities on the 
anion exchange gel TEAP-LH-20 and from their 
conversion to unconjugated lignans using a mild 
M/Z 
317 x 1 
406 x 2 
180 x 4 
500X6 
410 x 4 
442 x 1 
370 x 3 
solvolytic procedure, conditions that will not cleave 
glucuronide conjugates [8]. Furthermore, when the 
sulphate fractions were converted to TMS ether deriv- 
atives directly without prior solvolysis, TMS ether 
derivatives of the unconjugated lignans were readily 
formed. The derivatisation procedure was thus capa- 
ble of hydrolysing the sulphate conjugate, a reaction 
which has also been employed for the analysis of 
other aromatic sulphates [ 18,191. 
3.2. Quantitative excretion of lignan conjugates in 
wine 
The total excretion @g/day) and relative distribu- 
tion of the two lignans 2,3-his-(3’-hydroxybenzyl)- 
butyrolactone (I) and 2,3-bis~3’-hydroxyben~yl)- 
butane-l ,4diol (li), between conjugate classes are 
shown in table 1 for a limited number of normal sub- 
jects and one pregnant woman. The relative distribu- 
tion of these lignans within the conjugate groups was 
Fig.2. GC-MS analysis of Me ester-TMS ethers of intact lig- similar for all urine samples with the principal con- 
mm glucuronides isolated from urine. FIC chromato~ams of 
m/z 3 17 and m/z 406 are representative of the glucuronyl 
jugate being a glucuronide. Quantitatively 98% (range 
moiety, those of m/z 180,m/z 500 and m/z 410 of the 2,3- 
96.0-98.9) of the butyrolactone (I) and 92% (range 
his-(3’-hydroxybenzyl)-butane-l ,Ildiol structure (II) and 87.0-94.7) of the butanediol (II) was excreted as 
those of m/z 180, m/z 442 and m/z 370 of the 2,3-bis- glucuronide conjugates. Similar results have been 
(3’hydroxybenzyl)butyrolactone structure (1) (see text). obtained for the vervet monkey, baboon and rat. 
Table 1 
Distribution (%) of conjugates of the lignans 2,3-his-(3’-hydroxybenzyl)-butyrolactone (1) and 2,3-his-(3’-hydroxybenzyl)-butane- 
1 ,4-dial (II) and the total excretion &g/24 h) in urine from human subjects 
_ 
Subject Age Sex Unconjugated Glucuronides Monosulphates Disuiphates Total 
I II I II I II I 11 I II 
NA 6 Male 0.6 0.6 91.9 90.2 1.2 8.6 0.3 0.6 34.0 16.3 
KS 2.5 Male 0.5 0.9 96.3 93.0 2.8 5.6 0.4 0.5 94.3 81.6 
AM 12 Female fpre- 
menarche) 0.2 0.9 98.5 94.6 1.2 4.2 0.2 0.3 66.0 33.3 
AT-l 33 Female (cycle 
day 4) 0.3 <O.l 98.2 92.6 1.3 6.9 0.2 0.6 394.5 17.5 
AT-2 33 Female (cycle 
day 23) 0.2 <O.l 98.4 90.9 1.1 7.8 0.2 1.3 531.1 15.4 
BA 62 Female (post- 
menopausal) 0.1 <O.l 96.0 87.0 3.6 12.3 0.4 0.7 190.9 27.7 
BS 28 Female (preg- 
nant 7 weeks) 0.5 1.1 98.9 94.7 0.4 3.2 0.3 1.1 216.2 9.4 
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Lignans with one sulphate group comprised -2% 
(range 0.4-3.6) ar.d 7% (range 3.2-12.3) of the daily 
excretion of I and II, respectively. Only small amounts 
of lignans were identified as disulphates (0.2-I .3%). 
In spite of the precautions taken during collection of 
the urine it is possible that the small amounts of 
unconjugated lignans (0- 1.1%) detected in urine 
resulted from the hydrolysis of the lignan conjugates. 
In general, though the mode of conjugation of the 
lignans resembled that of steroid hormone metabo- 
lites [20] and although not proven yet, their conjuga- 
tion probably occurs in the liver. 
The daily excretion of 2,3-bis(3’-hydroxybenzyl)- 
butyrolactone (I) appeared to vary Gvith age and sex 
(table 1). The highest levels have been found in fertile 
women. The excretion of 2,3-his-(3’-hydroxybenzyl) 
butane.1 ,4diol (II) appeared to be less variable and 
thus ratios between I and II were found to be much 
higher for fertile women, including the pregnant 
women (about 23-34) compared with men and non- 
fertile women (about l-7). The presence of these 
two lignans in the urine from children is confirmed 
from the FIG chromatograms hown in fig.3, although 
the quantitative excretion of the two lignans in chil- 
dren has been found to be lower than in adults, and 
BOY 
I 
GIRL 
I 
442 ---A--- 
427 
A 263 A 
, / 1 , I I 
0 50 100 0 50 100 
SCAN NUMBER 
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5 IO IS 10 15 20 
MINUES 
Fig.3. GC-MS analyses of lignans in hydrolysed glucuronide 
fractions from the urine from a boy (16 years) and a girl 
(12 years). FIC chromatograms were constructed by the com- 
puter for characteristic ions given by TMS ethers of: 2,3-bis- 
(3’-hydroxybenzyl)-butane-l pdiol (II), m/z 180, m/z 500, 
m/z 410 andmjz 231 ;and 2,3_bis_(3’hydroxybenzyl)- 
butyrolactone (I), m/z 180, m/z 442 (MC), m/z 427 and 
mfz 263. 
almost undetectable in the first days of life [ 1,3]. 
The number of urine samples analysed in this 
study is small, and since the origin, metabolism and 
the physiological roie of these new lignans is pres- 
ently unknown, the significance of these results 
remains to be seen, 
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